Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 12Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia 7Hematologic Neoplasms 5Neuroblastoma 4Lymphoma 4Hodgkin Disease 4Graft vs Host Disease 4Primary Myelofibrosis 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Juvenile 3Rhabdomyosarcoma 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Large-Cell, Immunoblastic 2Burkitt Lymphoma 2Breast Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Sezary Syndrome 1Sarcoma, Myeloid 1

Interventions

Cyclophosphamide 4Rituximab 3cobomarsen 2Vincristine 2Prednisone 2Etoposide 2Doxorubicin 2thymoglobulin 1ponatinib 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1Vorinostat 1Tacrolimus 1Mycophenolic Acid 1Melphalan 1Imatinib Mesylate 1Ifosfamide 1Cytarabine 1Carmustine 1Carboplatin 1Busulfan 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immune System Diseases × thymoglobulin × Clear all
NCT02627573 2019-04-05

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

St. Petersburg State Pavlov Medical University

Phase 2 Terminated
32 enrolled
MyeloidOther hematologic neoplasm

Immune System Diseases, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡